Bimatoprost is a prostamide, a synthetic structural analog of prostaglandin F2α, primarily used to treat open-angle glaucoma and ocular hypertension by increasing aqueous humor outflow through the trabecular… Read more
























Bimatoprost is a prostamide, a synthetic structural analog of prostaglandin F2α, primarily used to treat open-angle glaucoma and ocular hypertension by increasing aqueous humor outflow through the trabecular meshwork and uveoscleral pathways. Beyond its ocular hypotensive applications, this drug is also indicated for the treatment of eyelash hypotrichosis. Pharmaceutical laboratories utilize this comprehensive collection of Bimatoprost reference standards, related impurities, and stable isotope-labelled compounds to support rigorous analytical method validation, impurity profiling, and quality control. These materials are essential for identifying and quantifying process-related impurities, synthetic intermediates, and degradation products formed via oxidation or hydrolysis. Furthermore, stable isotope-labelled standards provide critical internal references for quantitative mass spectrometry, ensuring that drug formulations meet established safety, stability, and efficacy requirements in accordance with global regulatory guidelines throughout the pharmaceutical product lifecycle.